Login / Signup

Correction to: Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS‑CoV‑2 3CL Protease Inhibitor.

Takayuki KatsubeSafwan KezborRyosuke ShimizuRyuji Kubota
Published in: Infectious diseases and therapy (2024)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus